Clinical Trial Update: Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence [Phase 4]

View source ↗

Summary

This Phase 4 trial examined whether nitrofurantoin (Macrobid) reduces urinary tract infections in patients receiving a sub-urethral sling for stress incontinenc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Incontinence
• Urinary Tract Infection

Drugs mentioned

• Macrobid (nitrofurantoin)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Stress Incontinence | Phase 4 | Status: COMPLETED | Results posted: 2016-10-11